Catalyst Wire Dossier Catalyst Wire Dossier

RTS,S/AS02A

RTS,S malaria vaccine with AS02A adjuvant · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for RTS,S/AS02A, covering 2016-09-21 to 2020-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults. [Phase 2]

See pricing